Ignite Creation Date:
2025-12-24 @ 4:49 PM
Ignite Modification Date:
2026-03-20 @ 4:05 AM
Study NCT ID:
NCT05513950
Status:
COMPLETED
Last Update Posted:
2025-08-14
First Post:
2022-08-17
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Monoclonal Antibody (mAb) in Patients With IPF (SAD).
Sponsor:
Chiesi Farmaceutici S.p.A.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CLI-10067AA1-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None